Studies showed that compared to free curcumin, the synthesized targeted drug reduces tumor volume in mice by inducing ROS, cell cycle arrest, and modulating NF-κB and Bax-mediated apoptosis pathways [41]. Here, NFKB1 is linked to neoplasm.